JP2006504435A5 - - Google Patents

Download PDF

Info

Publication number
JP2006504435A5
JP2006504435A5 JP2004553402A JP2004553402A JP2006504435A5 JP 2006504435 A5 JP2006504435 A5 JP 2006504435A5 JP 2004553402 A JP2004553402 A JP 2004553402A JP 2004553402 A JP2004553402 A JP 2004553402A JP 2006504435 A5 JP2006504435 A5 JP 2006504435A5
Authority
JP
Japan
Prior art keywords
amino acid
hiv
mutation
envelope protein
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004553402A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006504435A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/014721 external-priority patent/WO2004045495A2/en
Publication of JP2006504435A publication Critical patent/JP2006504435A/ja
Publication of JP2006504435A5 publication Critical patent/JP2006504435A5/ja
Pending legal-status Critical Current

Links

JP2004553402A 2002-05-10 2003-05-12 HIV−1のgp120のgp41への相互作用部位 Pending JP2006504435A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37905202P 2002-05-10 2002-05-10
PCT/US2003/014721 WO2004045495A2 (en) 2002-05-10 2003-05-12 Interacting site for gp41 on gp120 of hiv-1

Publications (2)

Publication Number Publication Date
JP2006504435A JP2006504435A (ja) 2006-02-09
JP2006504435A5 true JP2006504435A5 (https=) 2009-04-09

Family

ID=32326162

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004553402A Pending JP2006504435A (ja) 2002-05-10 2003-05-12 HIV−1のgp120のgp41への相互作用部位

Country Status (6)

Country Link
US (1) US20080057492A1 (https=)
EP (1) EP1553978A4 (https=)
JP (1) JP2006504435A (https=)
AU (1) AU2003299489B2 (https=)
CA (1) CA2483870A1 (https=)
WO (1) WO2004045495A2 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683136A (en) * 1985-03-06 1987-07-28 Scripps Clinic And Research Foundation Proteinaceous antigens with conformation-independent and conformation-dependent determinants
EP0651818B1 (en) * 1990-05-16 1999-01-07 Dana Farber Cancer Institute Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding
ES2115622T5 (es) * 1990-10-17 2003-03-16 Us Health Clones moleculares de hiv-1 y usos de los mismos.
US5696238A (en) * 1991-08-20 1997-12-09 Chiron Corporation Purified GP120 composition retaining natural conformation
US5505947A (en) * 1994-05-27 1996-04-09 The University Of North Carolina At Chapel Hill Attenuating mutations in Venezuelan Equine Encephalitis virus
ATE435034T1 (de) * 1998-08-04 2009-07-15 Jackson H M Found Military Med Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.

Similar Documents

Publication Publication Date Title
JP2004533208A5 (https=)
JP2020023567A5 (https=)
CN103347892B (zh) 单体和多聚体免疫原性肽
JP2008543314A5 (https=)
PL363071A1 (pl) Sposoby i kompozycje dla zmniejszenia replikacji HIV-1
JP2015509707A5 (https=)
US6716429B1 (en) Stabilization of envelope glycoprotein trimers by disulfide bonds introduced into a gp 41 glycoprotein ectodomain
JP2010532656A5 (https=)
CN104619718A (zh) 源自病毒蛋白的肽用作免疫原和配药成分
FR2766192A1 (fr) Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
HK1225739A1 (zh) 针对肺炎链球菌进行保护的富含脯氨酸的肽
JP2023184757A5 (https=)
WO1992004374A1 (fr) Nouveau polypeptide et medicament anti-vih prepare a partir de ce polypeptide
CN102112601B (zh) 新的融合蛋白及其用于制备针对丙型肝炎的疫苗的用途
JP2020509770A5 (https=)
JP2020117504A5 (https=)
EP1019511A2 (en) STABILIZATION OF ENVELOPE GLYCOPROTEIN TRIMERS BY DISULFIDE BONDS INTRODUCED INTO A gp41 GLYCOPROTEIN ECTODOMAIN
CA2602654A1 (en) Method for shielding functional sites or epitopes on proteins
JP2005512518A5 (https=)
JP2006504435A5 (https=)
EP0728015B1 (en) Method of producing a set of combinatorial polypeptide antigens
JP2011521648A5 (https=)
Lee et al. Structure-activity relationships of anti-HIV-1 peptides with disulfide linkage between D-and L-cysteine at positions i and i+ 3, respectively, derived from HIV-1 gp41 C-peptide
JP2010501580A5 (https=)
JP2025516139A5 (https=)